Fulminant myocarditis: Characteristics, treatment, and outcomes
Open Access
- 1 January 2018
- journal article
- review article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 19 (4) , 279-286
Abstract
Myocarditis is an inflammatory disease of the myocardium with a broad spectrum of clinical presentations, ranging from mild symptoms to severe heart failure. The course of patients with myocarditis is heterogeneous, varying from partial or full clinical recovery in few days to advanced low cardiac output syndrome requiring mechanical circulatory support or heart transplantation. Fulminant myocarditis (FM) is a peculiar clinical condition and is an acute form of myocarditis, whose main characteristic is a rapidly progressive clinical course with the need for hemodynamic support. Despite the common medical belief of the past decades, recent comprehensive data, including a recent registry that compared FM with acute non-FM, highlighted that FM has a poor inhospital outcome, often requires advanced hemodynamic support, and may result in residual left ventricular dysfunction in survivors. This review aimed to provide an updated practical definition of FM, including essentials in the diagnosis and management of the disease. Finally, the outcome of FM was critically revised according to the current published registries focusing on the topic.Keywords
This publication has 50 references indexed in Scilit:
- Resuscitation of non-postcardiotomy cardiogenic shock or cardiac arrest with extracorporeal life support: The role of bridging to interventionResuscitation, 2012
- MyocarditisThe Lancet, 2012
- Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support*Critical Care Medicine, 2011
- Management and Outcomes in Pediatric Patients Presenting with Acute Fulminant MyocarditisThe Journal of Pediatrics, 2011
- Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience☆European Journal of Cardio-Thoracic Surgery, 2011
- Usefulness of Immunosuppression for Giant Cell MyocarditisThe American Journal of Cardiology, 2008
- Fulminant myocarditisNature Clinical Practice Cardiovascular Medicine, 2008
- Outcome of acute fulminant myocarditis in childrenHeart, 2006
- Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenationEuropean Heart Journal, 2005
- National Survey of Fulminant Myocarditis in JapanCirculation Journal, 2002